Growth Factors

ACE-031

ActRIIB-Fc myostatin ligand-trap protein, 1mg vial

$230.00

Format Lyophilized powder, vial
Purity ≥99% (HPLC)
CAS 1169766-01-1
Documentation COA by request

This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.

FAQ

Common questions

What is ACE-031?+

A fusion protein combining ActRIIB's extracellular domain with human IgG1 Fc, acting as a myostatin ligand trap.

Was ACE-031 approved as a treatment?+

No — it was studied in Duchenne muscular dystrophy clinical trials, and that development program was discontinued.

What CAS number identifies ACE-031?+

1169766-01-1.

About

About ACE-031

ACE-031 is a soluble fusion protein combining the extracellular domain of activin receptor IIB (ActRIIB) with the Fc region of human IgG1, engineered as a ligand trap for myostatin and related TGF-beta-family ligands; it was studied in clinical trials for Duchenne muscular dystrophy before that program was discontinued. Third-party HPLC-verified purity (≥99% (HPLC)). For laboratory research use only.